Atlas Trials

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Clinical trial NCT04096014 · RECRUITING

Trial details

NCT number
NCT04096014
Sponsor
The Cleveland Clinic
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatic Encephalopathy
Start date
2019-09-16
Primary completion
2026-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.